Medpace Holdings (MEDP) Enterprise Value (2016 - 2026)
Medpace Holdings' (MEDP) quarterly Enterprise Value came in at $14.3 billion in Q2 2026, up 62.82% on a YoY basis from $8.8 billion in Q2 2025, and up 9.32% quarter-over-quarter from $13.1 billion in Q1 2026.
Analysis
Medpace Holdings (MEDP) Enterprise Value (2016 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Enterprise Value for 11 consecutive years, with $14.3 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Enterprise Value rose 62.82% year-over-year to $14.3 billion; the trailing twelve-month figure through Jun 2026 stood at $14.3 billion (up 62.82% YoY), and the FY2025 full-year result was $15.4 billion, up 62.38% from the prior year.
- Enterprise Value advanced to $14.3 billion in Q2 2026 per MEDP's latest filing, from $13.1 billion in the prior quarter.
- Across five years, Enterprise Value topped out at $15.4 billion in Q4 2025 and bottomed at $4.6 billion in Q2 2022.
- Historically, Enterprise Value has averaged $9.4 billion across 5 years, with a median of $9.0 billion in 2023.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 112.1% in 2024, then declined 28.61% in 2025.
- Over 5 years, Enterprise Value stood at $6.6 billion in 2022, then surged by 39.62% to $9.2 billion in 2023, then increased by 3.55% to $9.5 billion in 2024, then surged by 62.38% to $15.4 billion in 2025, then dropped by 7.51% to $14.3 billion in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered $14.3 billion, $13.1 billion, and $15.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.28 Bn |
| Mar 31, 2026 | 13.06 Bn |
| Dec 31, 2025 | 15.44 Bn |
| Sep 30, 2025 | 14.20 Bn |
| Jun 30, 2025 | 8.77 Bn |
| Mar 31, 2025 | 8.65 Bn |
| Dec 31, 2024 | 9.51 Bn |
| Sep 30, 2024 | 9.72 Bn |
| Jun 30, 2024 | 12.26 Bn |
| Mar 31, 2024 | 12.11 Bn |
| Dec 31, 2023 | 9.18 Bn |
| Sep 30, 2023 | 7.33 Bn |
| Jun 30, 2023 | 7.30 Bn |
| Mar 31, 2023 | 5.71 Bn |
| Dec 31, 2022 | 6.58 Bn |
| Sep 30, 2022 | 4.86 Bn |
| Jun 30, 2022 | 4.60 Bn |
| Mar 31, 2022 | 5.42 Bn |
| Dec 31, 2021 | 7.38 Bn |
| Sep 30, 2021 | 6.40 Bn |